In a recent study posted to the bioRxiv* preprint server, researchers identified a novel antiviral pathway different from the interferon (IFN) pathway that inhibited poxvirus(es) replication. Study: A ...
Scientists studying how poxviruses evade natural defences in human cells have identified a new approach to treatment that may be more durable than current treatments. This follows their discovery of ...
The drug tecovirimat is currently in use for the treatment of mpox -- the disease caused by monkeypox virus -- that spread worldwide in 2022. Tecovirimat is an anti-poxviral drug, and its use is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback